These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 29457214

  • 1. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
    Gupta P, Choksi M, Goel A, Zachariah U, Sajith KG, Ramachandran J, Chandy G, Kurian G, Rebekah G, Eapen CE.
    Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
    [Abstract] [Full Text] [Related]

  • 2. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
    Sinha S, Taly AB.
    J Neurol Sci; 2008 Jan 15; 264(1-2):129-32. PubMed ID: 17765927
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson's disease.
    Zhang J, Xiao L, Yang W.
    BMC Neurol; 2020 Jun 27; 20(1):255. PubMed ID: 32593295
    [Abstract] [Full Text] [Related]

  • 5. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM.
    QJM; 2011 Sep 27; 104(9):775-8. PubMed ID: 21622540
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients.
    Dzieżyc K, Karliński M, Litwin T, Członkowska A.
    Eur J Neurol; 2014 Feb 27; 21(2):332-7. PubMed ID: 24313946
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of chelation therapy in pediatric Wilson's disease: Liver and endoscopic outcome.
    Das MC, Sen Sarma M, Srivastava A, Yachha SK, Poddar U.
    J Hepatobiliary Pancreat Sci; 2021 Apr 27; 28(4):336-345. PubMed ID: 32745371
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC, Hassan Y, Aziz NA, Ghazali R, Awaisu A.
    J Clin Pharm Ther; 2007 Feb 27; 32(1):101-7. PubMed ID: 17286794
    [Abstract] [Full Text] [Related]

  • 14. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease.
    Martins da Costa C, Baldwin D, Portmann B, Lolin Y, Mowat AP, Mieli-Vergani G.
    Hepatology; 1992 Apr 27; 15(4):609-15. PubMed ID: 1551638
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V, Di Leo V, Lamboglia F, Bowlus CL, Tseng SC, D'Incà R, Irato P, Burra P, Martines D, Sturniolo GC.
    Scand J Gastroenterol; 2007 Dec 27; 42(12):1495-500. PubMed ID: 17994470
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Resolution of decompensated cirrhosis from Wilson's disease with zinc monotherapy: a potential therapeutic option?
    Lee VD, Northup PG, Berg CL.
    Clin Gastroenterol Hepatol; 2006 Aug 27; 4(8):1069-71. PubMed ID: 16793346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.